Skip to main content
. 2017 May 23;55(6):1638–1649. doi: 10.1128/JCM.02316-16

TABLE 1.

MIC frequency distributions for imipenem against carbapenemase-positive isolates of Enterobacteriaceae collected by the SMART global surveillance program from 2008 to 2014

Isolate genotype (no. of isolates) No. (%) of isolates with indicated imipenem MIC (μg/ml)b
0.12 0.25 0.5 1 2 4 8 >8
All carbapenemase-positive isolates (1,493)a 3 (0.2) 10 (0.7) 27 (1.8) 101 (6.8) 206 (13.8) 206 (13.8) 245 (16.4) 695 (46.6)
    KPC (794) 2 (0.3) 16 (2.0) 66 (8.3) 103 (13.0) 136 (17.1) 471 (59.3)
    NDM (290) 2 (0.7) 28 (9.7) 70 (24.1) 190 (65.5)
    OXA-48-like (300) 2 (0.7) 9 (3.0) 22 (7.3) 78 (26.0) 106 (35.3) 42 (14.0) 18 (6.0) 23 (7.7)
    VIM (92) 3 (3.3) 13 (14.1) 27 (29.3) 22 (23.9) 27 (29.3)
    IMP (40) 1 (2.5) 1 (2.5) 3 (7.5) 3 (7.5) 19 (47.5) 7 (17.5) 3 (7.5) 3 (7.5)
    GES (3) 2 (66.7) 1 (33.3)
a

The 1,493 carbapenemase-positive isolates included 1,485 isolates that were ertapenem nonsusceptible and 8 isolates that were ertapenem susceptible and phenotypically ESBL positive. Twenty-four isolates carried two carbapenemases: KPC plus VIM (KPC+VIM) (Greece, 3 isolates); KPC+NDM (Colombia, 1 isolate); KPC+OXA-48-like (Argentina, 1 isolate; Italy, 1 isolate; Morocco, 1 isolate); NDM+OXA-48-like (Egypt, 3 isolates; India, 1 isolate; Jordan, 1 isolate; Romania, 1 isolate; Serbia, 4 isolates; Tunisia, 1 isolate; United Arab Emirates, 2 isolates; Vietnam, 2 isolates); VIM+OXA-48-like (Croatia, 1 isolate; Turkey, 1 isolate). One isolate carried three carbapenemases: OXA-48-like+NDM+VIM (Turkey).

b

Imipenem MIC breakpoints: susceptible, ≤1μg/ml (gray shading); intermediate, 2 μg/ml; resistant, ≥4 μg/ml (11).